Evofem Biosciences (EVFM) Assets (2014 - 2026)
Evofem Biosciences' Assets was $7.52 million in Q2 2026, down 47.7% from $14.38 million a year earlier but up 1.1% from the prior quarter.
Powered by 
Analysis
Evofem Biosciences (EVFM) Assets (2014 - 2026) Analysis & Trends
At the end of FY2025, Assets at Evofem Biosciences came in at $20.27 million, down 14.8% from FY2024.
- Assets shows a five-year compound annual growth rate of -28.7% (FY2020 to FY2025).
- In earlier years, Assets was $23.79 million in FY2024 (+125.4%), $10.55 million in FY2023 (-58.1%), $25.16 million in FY2022 (-40.8%) and $42.51 million in FY2021 (-61.3%).
- Quarterly Assets has moved between $7.44 million (Q1 2026) and $67.43 million (Q3 2021) over five years.
- Compared with a year earlier, Assets has declined for four straight quarters, with growth averaging 22.9% over the last eight quarters.
- The best year-over-year quarter for Assets over five years was Q4 2024 (growth of 125.4%); the worst was Q2 2023 (a decline of 73.7%).
- Per Business Quant data, EVFM's Assets in the three quarters before Q2 2026 was $7.44 million (Q1 2026), $20.27 million (Q4 2025) and $13.81 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,171.69 Bn | 1,140.28 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 649.22 Bn | 569.08 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 504.17 Bn | 477.29 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 366.35 Bn | 320.73 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 303.54 Bn | 267.53 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 269.49 Bn | 243.18 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 242.61 Bn | 198.01 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 195.09 Bn | 169.29 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 172.48 Bn | 119.12 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Evofem Biosciences | 878,961.72 | 878,961.72 | 2.12 Mn | 7.52 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.52 Mn |
| Mar 31, 2026 | 7.44 Mn |
| Dec 31, 2025 | 20.27 Mn |
| Sep 30, 2025 | 13.81 Mn |
| Jun 30, 2025 | 14.38 Mn |
| Mar 31, 2025 | 12.88 Mn |
| Dec 31, 2024 | 23.79 Mn |
| Sep 30, 2024 | 23.94 Mn |
| Jun 30, 2024 | 8.55 Mn |
| Mar 31, 2024 | 8.22 Mn |
| Dec 31, 2023 | 10.55 Mn |
| Sep 30, 2023 | 13.32 Mn |
| Jun 30, 2023 | 14.07 Mn |
| Mar 31, 2023 | 26.03 Mn |
| Dec 31, 2022 | 25.16 Mn |
| Sep 30, 2022 | 42.28 Mn |
| Jun 30, 2022 | 53.47 Mn |
| Mar 31, 2022 | 34.57 Mn |
| Dec 31, 2021 | 42.51 Mn |
| Sep 30, 2021 | 67.43 Mn |
API Access
Evofem Biosciences Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=EVFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "EVFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=EVFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();